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Buruli ulcer (BU) is a devastating, necrotizing, tropical skin disease caused by infections withMycobacterium
ulcerans. In contrast to other mycobacterioses, BU has been associated with minimal or absent inflammation.
However, here we show that in the mouse M. ulcerans induces persistent inflammatory responses with viru-
lence-dependent patterns. Mycolactone-positive, cytotoxic strains are virulent for mice and multiply progres-
sively, inducing both early and persistent acute inflammatory responses. The cytotoxicity of these strains leads
to progressive destruction of the inflammatory infiltrates by postapoptotic secondary necrosis, generating
necrotic acellular areas with extracellular bacilli released by the lysis of infected phagocytes. The necrotic
areas, always surrounded by acute inflammatory infiltrates, expand through the progressive invasion of healthy
tissues around the initial necrotic lesions by bacteria and by newly recruited acute inflammatory cells. Our
observations show that the lack of inflammatory infiltrates in the extensive areas of necrosis seen in advanced
infections results from the destruction of continuously produced inflammatory infiltrates and not from M.
ulcerans-induced local or systemic immunosuppression. Whether this is the mechanism behind the predomi-
nance of minimal or absent inflammatory responses in BU biopsies remains to be elucidated.
Pathogenic mycobacteria are intracellular parasites that are
responsible for several clinically important infections in hu-
mans and animals. The most frequent mycobacterial infections
in humans are caused by Mycobacterium tuberculosis and M.
leprae. However, a unique group of mycobacterioses has been
emerging and comprises infections caused by M. marinum, M.
hemophilum, and M. ulcerans (12). These are slow-growing
mycobacteria with some genetic relatedness (71) and common
peculiar characteristics. These mycobacteria have optimal
growth temperatures of 28 to 33°C and infect primarily the
cooler parts of the body, mainly the skin. They have cytotoxic
activity (17, 56, 57) and, as a consequence, produce necrotizing
lesions (3, 7, 12, 72).
Buruli ulcer (BU), caused by M. ulcerans, has become the
third most prevalent mycobacteriosis throughout the world,
after tuberculosis and leprosy, with higher incidence in the
tropical regions of western and central Africa (11, 74). BU is a
devastating skin disease characterized by different clinical
forms, including nonulcerative subcutaneous nodules, papules,
edema, and plaques, that can eventually progress to ulcerative
forms and often to extensive necrotic lesions (11, 74). Osteo-
myelitis has been described as a complication of M. ulcerans
infection, particularly in some African regions (11, 39).
Genetic analyses showed that M. marinum and M. ulcerans
are very closely related to M. tuberculosis (71), a mycobacte-
rium that also exhibits some cytotoxicity (14, 19, 37, 43), which
contributes to the necrotic lesions seen in tuberculosis (43).
Recently, genes in the extRD1 region have been implicated in
the cytotoxic activity of M. tuberculosis and M. marinum (20).
However, M. ulcerans is the most necrotizing of all mycobac-
teria due to the secretion of mycolactone, an unique polyketide
lipid exotoxin that has a potent necrotizing activity associated
with extensive ulcerative lesions characteristic of the disease
(22, 23). M. ulcerans mycolactone is considered the major
pathogenicity factor in BU, and the genes that encode the
biochemical machinery for its synthesis are carried on a 147-kb
plasmid (69).
The inflammatory response to mycobacterial infections is
characterized histopathologically by an early, acute, predomi-
nantly neutrophilic response (51, 59, 60, 62), which changes
over time to a chronic, mononuclear, granulomatous pattern
(10, 36). The histopathology of lesions produced by M. tuber-
culosis, M. marinum, or M. hemophilum shows these typical
features of mycobacterial infections (3, 7, 12, 44, 72). It is
therefore intriguing that M. ulcerans, despite being related to
those mycobacteria, would produce a disease where minimal or
absent inflammatory responses have been predominantly ob-
served (6, 8, 9, 27, 30, 31). This view gained a consensus status
and became a hallmark of the histopathology of M. ulcerans
infection in human disease (1, 12, 15, 21–25, 35, 45, 48, 52, 64).
Experimental M. ulcerans infections in mice, rats, guinea pigs,
and nine-banded armadillos led to contradictory observations
regarding induction of inflammatory responses. In some stud-
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ies, the occurrence of an inflammatory response was reported
(38, 40, 57), but other studies showed minimal inflammation
associated with M. ulcerans infection (22, 23, 75). Moreover,
the dynamics of the infection process and host inflammatory
response at different stages of infection with M. ulcerans are
still poorly understood.
The present study was undertaken to evaluate the different
stages of experimental M. ulcerans infection and associated
cellular inflammatory responses. We examined the cytotoxicity
and pathogenicity for mice of different clinical isolates of M.
ulcerans by evaluating cell death of infected macrophages in
vitro and lesions produced in a footpad mouse model of infec-
tion. We analyzed M. ulcerans-induced disease from the early
stage of infection until later stages associated with ulceration,
which allowed us to characterize the dynamics of the infectious
process. We found that the mycolactone-producing strains
have cytotoxic activity and proliferate in mouse footpads, in-
ducing pathology, while the mycolactone-negative strain is
noncytotoxic and nonvirulent. We also found that M. ulcerans
consistently induces an early, acute neutrophilic inflammatory
response that is independent of virulence, followed by pro-
longed cellular responses that differ according to the strain.
With strains virulent for mice, the acute inflammatory infiltrate
persisted throughout infection and consisted primarily of neu-
trophils and some macrophages and lymphocytes surrounding
a central, expanding, necrotic acellular focus. In contrast, with
the avirulent strain, the initial acute inflammatory response
switched to a chronic inflammatory response with a persistent
mononuclear infiltrate with few neutrophils, associated with
granuloma-like structures and the absence of necrosis.
MATERIALS AND METHODS
Mycobacterial strains and preparation of inocula. The M. ulcerans strains
used in this study were selected based on our preliminary studies that showed
different degrees of virulence in mice. Moreover, the genetic and phenotypic
characteristics of these strains, including production of mycolactone, had been
previously described (4, 5, 45, 67). The strains are from the collection of the
Institute of Tropical Medicine (ITM), Antwerp, Belgium, where they have been
kept freeze-dried at 80°C before being passaged to Lo¨wenstein-Jensen (LJ)
medium for the present study, as well as for recently published studies on their
ability to produce mycolactone (45) and, in the case of strains 5114 and 98-912,
on the structure of the plasmid that carries genes responsible for mycolactone
synthesis (68). Strain 5114 was isolated from a case of ulcerative BU in Mexico
in 1953 and was received in 1965 at the ITM. The ITM 5114 strain does not
produce mycolactones (45) due to the loss of key genes involved in mycolactone
synthesis (68). However, its growth characteristics on LJ and in 7H9 media as
well as within cultured murine bone marrow-derived macrophages (BMDM) are
comparable to those of the other two strains used (not shown). Strain 97-1116
was isolated from a plaque form of BU in Benin in 1997 and was found to
produce mycolactones A/B (45). Strain 98-912 was isolated in China in 1997 from
a case of ulcer; it produces mycolactones A/B (45), but it has recently been shown
that the chemical structure of mycolactones A/B produced by this strain is slightly
different from that of mycolactones A/B produced by an African strain (34). The
clinical isolates were grown on LJ medium at 32°C for approximately 2 months.
M. ulcerans was recovered from slants of LJ medium, diluted in phosphate-
buffered saline (PBS) to a final concentration of 1 mg/ml, and vortexed vigor-
ously using 2-mm glass beads. In all experiments, the number of acid-fast bacilli
(AFB) in inocula was determined according to the method of Shepard and
McRae (61), using Ziehl-Neelsen (ZN) staining (Merck, Darmstadt, Germany).
The suspensions obtained according to this method revealed more than 90%
viable cells (viability was assessed with the LIVE/DEAD Baclight kit from Mo-
lecular Probes, Leiden, The Netherlands) and minimal clump formation.
Animals. Eight-week-old female BALB/c mice were obtained from Charles
River (Barcelona, Spain) and were housed under specific-pathogen-free condi-
tions with food and water ad libitum.
Culture of murine bone-marrow derived macrophages. Macrophages were
derived from the bone marrow as follows. Mice were euthanatized with CO2 and
femurs removed under aseptic conditions. Bones were flushed with 5 ml cold
Hanks’ balanced salt solution (HBSS) (Gibco, Paisley, United Kingdom). The
resulting cell suspension was centrifuged at 500  g and resuspended in Dul-
becco’s modified Eagle’s medium (DMEM) (Gibco) supplemented with 10 mM
HEPES (Sigma, St. Louis, MO), 1 mM sodium pyruvate (Gibco), 10 mM glu-
tamine (Gibco), 10% heat-inactivated fetal bovine serum (Sigma), and 10% L929
cell conditioned medium (complete DMEM [cDMEM]). To remove fibroblasts
or differentiated macrophages, cells were cultured for a period of 4 hours on cell
culture dishes (Nunc, Naperville, IL) with cDMEM. Nonadherent cells were
collected with warm HBSS, centrifuged at 500  g, distributed in 24-well plates
at a density of 5 105 cells/well, and incubated at 37°C in a 5% CO2 atmosphere.
A 0.1-ml amount of L929 cell conditioned medium was added 4 days after
seeding, and medium was renewed on the seventh day. After 10 days in culture,
cells were completely differentiated into macrophages. Twelve hours before
infection, macrophages were incubated at 32°C in a 5% CO2 atmosphere and
maintained until the end of the experimental infection as described elsewhere
(50).
Cytopathic effect ofM. ulcerans strains on BMDM. Bacterial suspensions were
prepared as described above and further diluted in cDMEM before infecting
macrophage monolayers. M. ulcerans suspensions (0.2 ml) were diluted in cD-
MEM and added to each well in order to obtain a multiplicity of infection (MOI)
of 1:1 (bacteria/macrophage ratio). Cells were incubated for 4 h at 32°C in a 5%
CO2 atmosphere and then washed four times with warm HBSS to remove
noninternalized bacteria and reincubated in cDMEM for a maximum period of
8 days. To confirm the MOI, counting of AFB in infected macrophages was
performed at the beginning of experimental infection as described previously
(61). The cytopathic effect of different strains of M. ulcerans on macrophages was
monitored for indicators of cytopathicity by using a phase-contrast microscope
(22, 23) and by terminal deoxynucleotidyl transferase-mediated dUTP nick end
labeling (TUNEL) staining by using an in situ cell death detection kit with
fluorescein (Roche Diagnostics, Mannheim, Germany) according to the manu-
facturer’s instructions. The coverslips were mounted in the antifading medium
Vectashield (Vector, Peterboroug, United Kingdom) with 4 g/ml of propidium
iodide. TUNEL-positive nuclei stain yellow-green, and normal nuclei stain red.
Cells were analyzed by fluorescence microscopy with a Zeiss Axioskop2 Plus
microscope. Digital images were captured by using a Axiocam HRc camera
(Zeiss, Hallbergmoos, Germany). As a control for cytotoxic activity of M. ulcer-
ans strains, uninfected BMDM were analyzed at the same time intervals.
Peritoneal model of infection. Mice were infected in the peritoneal cavity with
0.1 ml of M. ulcerans suspensions containing 6 log10 M. ulcerans strain 5114,
97-1116, or 98-912 AFB; PBS was used as a control. At different time points after
infection, four mice per group were sacrificed, and peritoneal cells were recov-
ered by peritoneal lavage using 4 ml of PBS. Total leukocyte numbers were
determined, and differential leukocyte counts were performed using cytospin
preparations fixed with 10% formol in ethanol and stained with Hemacolor
(Merck).
Footpad model of infection. Mice were infected in the left hind footpad with
0.03 ml of M. ulcerans suspensions containing the numbers of AFB indicated for
each experiment. The right hind footpad was used as a control. In other exper-
iments, mice were infected in the left hind footpad with M. ulcerans 98-912
several days before inoculation of the contralateral footpad with 5 log10 AFB of
the same strain. In all experiments, for ethical reasons, mice were sacrificed after
ulceration of footpads.
Assessment of footpad swelling and bacterial growth. After infection, as an
index of lesion development, footpad swelling of eight infected mice from each
group was measured over time by using a caliper to measure the diameter of the
frontal area of the footpad. M. ulcerans growth in footpad tissues of infected mice
was evaluated. Briefly, tissue specimens were carefully minced on a petri dish
after tendons and bones had been removed. The tissues were resuspended in 2
ml PBS containing 0.04% Tween 80 (Sigma) and vortexed vigorously with 2-mm
glass beads to obtain homogenized suspensions. At different times postinfection,
AFB counts were performed on samples from five footpads in each group by
using the method of Shepard and McRae (61).
Histological studies. All excised tissues from control and infected footpads
were fixed in 10% phosphate-buffered formalin. The whole paws were decalcified
(Thermo Shandon TBD-1, Runcorn, United Kingdom) and embedded in paraf-
fin. Longitudinal sections of the paws (4 m) were processed for light micro-
scopic studies after hematoxylin-eosin (HE) or ZN staining. For each sample,
serial longitudinal sections of the entire paw were viewed under the microscope
to ensure that representative areas of the lesions were analyzed. Several animals
were studied for each time point as indicated in Table 1, and all histological
6300 OLIVEIRA ET AL. INFECT. IMMUN.
observations were carried out blind. For TUNEL staining of paraffin sections, the
In Situ Cell Death Detection Kit, AP (Roche Diagnostics), was used according
to the manufacturer’s instructions with the final contrast stain omitted. TUNEL-
positive nuclei stain red; normal nuclei are unstained.
Statistical analysis. Statistical significance of values was determined using the
Student t test.
RESULTS
We first characterized the in vitro cytotoxicity as well as the
in vivo pathology induced by three selected strains of M. ul-
cerans. Next, we analyzed the cellular inflammatory responses
induced by these strains in the mouse peritoneal cavity and
footpads.
M. ulcerans clinical isolates show different cytotoxicities
against BMDM. The genetic heterogeneity within M. ulcerans
clinical isolates, which is caused by several factors, including
instability and mutability of genes encoding the machinery for
the synthesis of mycolactone, results in variable degrees of
toxigenicity (68, 69). Cell lines treated with M. ulcerans culture
filtrates, acetone-soluble lipids containing mycolactone, or pu-
rified mycolactone exhibit typical cytopathic changes (21–23,
45). However, the cytotoxicity of live M. ulcerans bacilli from
different clinical isolates on infected macrophages has not been
characterized. We first established an in vitro model of BMDM
infection at 32°C in order to evaluate the cytotoxic activities of
the different clinical isolates of M. ulcerans used in this study.
Macrophage cultures were infected with M. ulcerans strain
5114, 97-1116, or 98-912 at a 1:1 MOI. No significant alter-
ations were found in monolayers infected with strain 5114
compared to uninfected BMDM at 4 days (Fig. 1A and B) and
at 8 days (data not shown) after infection. In contrast, strains
98-912 and 97-1116 are cytotoxic for macrophages, as assessed
by cell rounding, shrinkage, and detachment of more than 90%
of macrophages at 4 days (Fig. 1C and D). Positive TUNEL
staining in a high proportion of macrophages (Fig. 1E) points
to the apoptotic nature of that cytotoxicity.
FIG. 1. Cytotoxicity of M. ulcerans clinical isolates to BMDM.
BMDM were not infected (A) or were infected with M. ulcerans strain
5114 (B), 97-1116 (C), or 98-912 (D and E) at an MOI of 1:1. Mac-
rophages were photographed 4 days after infection by phase-contrast
microscopy (A to D) or with fluorescence microscopy for samples
stained with TUNEL (E). Positive TUNEL staining (yellow-green flu-
orescent nuclei in E) points to the apoptotic nature of cell death
induced by the cytotoxic strain 98- 912. Bars, 50 m.
TABLE 1. Assessment of histopathological features after infection with different strains of M. ulcerans
Histopathological parameter M. ulcerans strain
No. of positive cases/total studied cases on postinfection day:
2 7 15 24 43 60
Acute inflammation (predominant
neutrophilic infiltrate)
98–912 5/5 2/6 6/6 6/6 —a —
97–1116 3/3 4/6 5/6 6/6 2/2 —
5114 3/3 2/6 0/6 0/5 NDb 0/6
Chronic inflammation (predominant
macrophagic-lymphocytic infiltrate)
98–912 0/5 4/6 0/6 0/6 — —
97–1116 0/3 1/6 1/6 0/6 0/2 —
5114 0/3 4/6 6/6 5/5 ND 6/6
Presence of granuloma-like structures 98–912 0/5 0/6 0/6 0/6 — —
97–1116 0/3 0/6 0/6 0/6 0/2 —
5114 0/3 0/6 6/6 5/5 ND 6/6
Leukocyte destruction (apoptosis/necrosis) 98–912 5/5 6/6 6/6 6/6 — —
97–1116 3/3 6/6 6/6 6/6 2/2 —
5114 0/3 0/6 0/6 0/5 ND 0/6
Subcutaneous tissue necrosis 98–912 0/5 0/6 3/6 6/6 — —
97–1116 0/3 0/6 3/6 6/6 2/2 —
5114 0/3 0/6 0/6 0/5 ND 0/6
a —, animals were sacrificed after emergence of ulceration.
b ND, not done.
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Since (i) the mycolactone-negative strain 5114 is noncyto-
toxic for macrophages, whereas the mycolactone-positive
strains 98-912 and 97-1116 are cytotoxic, and (ii) this cytotox-
icity is associated with cytopathic changes similar to those
induced in fibroblast and macrophage cell lines by purified
mycolactone (22, 23), we conclude that cytotoxicity of strains
98-912 and 97-1116 for BMDM correlates with mycolactone
production.
Cytotoxic M. ulcerans isolates are virulent for mice. We
measured over time the mean swelling of footpads infected
with different strains of M. ulcerans as a macroscopic parame-
ter for monitoring pathology. Significant differences were
found in the mean swelling after inoculation of 5 log10 AFB of
each M. ulcerans strain in the mouse footpad. Swelling was
evident in mice infected with the cytotoxic M. ulcerans strain
98-912 during the second week of infection (Fig. 2A and B),
and ulceration occurred by the end of the fourth week. Strain
97-1116 induced swelling of the footpad during the fourth
week (Fig. 2A) and ulceration during the seventh week. In
contrast, the noncytotoxic M. ulcerans strain 5114 was found
not to induce significant swelling of the footpad up to 90 days
of infection (Fig. 2A and B) or at 12 months postinoculation
(data not shown). Infection of mice with 2 log10 AFB of M.
ulcerans 98-912 showed that this strain still induced footpad
swelling, albeit delayed, at concentrations 1,000-fold lower
than the inoculum of M. ulcerans 5114 that did not induce
measurable swelling (Fig. 2B).
To assess if the severity of lesions induced by M. ulcerans
strains was associated with their capacity to proliferate in the
host, we performed AFB counts in footpad homogenates. We
found that M. ulcerans strains proliferated differently over the
experimental period of infection. AFB counts following infec-
tion by M. ulcerans 98-912 increased significantly (P  0.001)
from 5.02 log10 to 7.90 log10 between days 0 and 26 of infection
(Fig. 2C). In mice infected with strain 97-1116, AFB counts
increased approximately 2 log10 (P  0.001) from day 0 to day
39 postinfection (Fig. 2C). Conversely, M. ulcerans strain 5114
increased only from 5.06 log10 to 5.69 log10 (P 0.01) between
days 0 and 16 postinfection and reached a plateau after 3
months (Fig. 2C) that remained stable after 12 months of
infection (data not shown).
These results show that mycolactone-positive, cytotoxic
strains of M. ulcerans are virulent for mice, while the mycolac-
tone-negative, noncytotoxic strain is avirulent.
M. ulcerans induces an early acute inflammatory response in
the peritoneal cavity. Mycobacterioses, such as those caused by
the M. ulcerans-related species M. tuberculosis, M. marinum,
and M. hemophilum, have been consistently associated with
acute and chronic recruitment of inflammatory cells to the site
of infection (3, 7, 10, 36, 44, 51, 59, 60, 62, 72). However,
reports on the histopathology of M. ulcerans infection are in-
triguing, since several authors describe minimal or absent cel-
lular inflammation.
The mouse peritoneal model of infection has been used to
characterize the inflammatory cellular response to mycobacte-
rioses because it allows a precise qualitative and quantitative
analysis of leukocyte populations (2, 51, 62). We used this
model to evaluate quantitatively the early inflammatory re-
sponse to M. ulcerans inoculation. After intraperitoneal infec-
tion with 6 log10 M. ulcerans 5114 AFB, 97-1116, or 98-912,
FIG. 2. Footpad swelling and proliferation of different strains of M.
ulcerans. Panels A and C show swelling and AFB counts, respectively,
of BALB/c mice footpads infected subcutaneously with 5.0 log10 AFB
of M. ulcerans 98-912 (■), 5.3 log10 AFB of M. ulcerans 97-1116 (Œ), or
5.1 log10 AFB of M. ulcerans 5114 (F). Panel B shows swelling of
footpads infected with 5.5 log10 AFB (■) or 2.5 log10 AFB () of M.
ulcerans 98-912 or 5.5 log10 AFB of M. ulcerans 5114 (F). Footpad
swelling was measured in eight mice from each group. Significant
differences in footpad swelling were calculated by comparing infected
and noninfected mice. Significant differences in AFB counts were
determined by comparing the bacterial loads of five footpads from
each group with the respective initial inoculum. Calculations were
performed using Student’s t test (*, P  0.05; **, P  0.01; ***, P 
0.001). Mice were sacrificed for ethical reasons after the emergence of
ulceration (†). Results are from one representative of three indepen-
dent experiments. Error bars indicate standard deviations.
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peritoneal exudates were collected at different time points.
Total cell counts and differential leukocyte quantification were
performed over a 2-week period. We found a significant re-
cruitment of neutrophils and macrophages in mice infected
with strains 5114 and 98-912 (Fig. 3) and 97-1116 (data not
shown). The number of neutrophils increased more than 50-
fold (P  0.001), peaked at 8 h postinfection, and declined
afterwards but remained 10-fold above the initial value (Fig.
3). The number of monocytes/macrophages increased signifi-
cantly 7 days after inoculation (P  0.05) (Fig. 3). No signifi-
cant differences in other leukocyte populations were detected.
Control mice injected intraperitoneally with PBS did not show
a significant influx of neutrophils or macrophages (data not
shown).
These results show for the first time that early recruitment of
high numbers of neutrophils followed by an influx of mono-
cytes/macrophages is a feature of M. ulcerans infection in the
mouse, irrespective of the virulence of the isolates.
M. ulcerans induces extensive inflammatory responses in the
mouse footpad. Experimental infections of the mouse tail, ear,
or footpad present several advantages over the peritoneal
model for studying long-term infections by M. ulcerans, not
only because of the nonpermissive temperature of the perito-
neal cavity but also because it parallels the BU disease that
affects the skin and subcutaneous tissue. Therefore, we used
the footpad model of infection in order to characterize differ-
ent phases of the inflammatory response to infection with M.
ulcerans.
We performed a semiquantitative blind assessment of sev-
eral histopathological parameters in sections of hind footpad
tissue infected with 5 log10 AFB of M. ulcerans 98–912, 97-
1116, or 5114, as summarized in Table 1. We found that the
three strains induced an early and intense acute inflammatory
cellular response in infected footpads. Within the first hours
after inoculation, we observed acute inflammatory responses
showing a predominance of neutrophils with scattered macro-
phages and lymphocytes (Fig. 4A, B, G, H, M, and N), and with
numerous bacilli within neutrophils and macrophages (not
shown), as previously described (16).
However, the progression of histological features associated
with pathology during experimental infection is largely depen-
dent on the virulence of the M. ulcerans strain. Leukocyte
destruction became apparent in the initial acute inflammatory
infiltrate as early as 24 h after inoculation of the mouse-viru-
lent strains 98-912 and 97-1116, as described in more detail in
the next section. This cell death process leads to the produc-
tion of necrotic, acellular foci (Fig. 4E, F, K, and L) that
continuously expand during infection. The centrifugal ad-
vancement of cell destruction leaves behind cell debris and
freed extracellular bacilli that accumulate in the necrotic areas
(Fig. 5A, D, F, and G). This is accompanied by progressive
invasion of healthy tissues by acute inflammatory infiltrates
around the areas where previous infection led to necrotic de-
struction of acute infiltrates (Fig. 4E and K and 5A and D).
The initiation of a switch from acute infiltrates, predominantly
neutrophilic, to infiltrates with a majority of mononuclear cells,
characteristic of chronic inflammation, as seen in some mice at
day 7 postinfection, is not fully accomplished (Table 1). In-
stead, in the boundary between the expanding necrotic, acel-
lular areas and the surrounding normal tissue, a band of acute
cellular infiltrate is permanently present (Fig. 4C to F and I
and L and 5A and D). The central necrotic area shows a high
number of extracellular bacilli (Fig. 4F and L and 5A, D, F,
and G), but the surrounding infiltrate of neutrophils, macro-
phages, and lymphocytes shows intracellular bacilli, mainly in
macrophages (Fig. 5B, C, and E). As a result of the progression
of this process, by the second or third week of infection with
strain 98-912 or 97-1116, respectively, histological features of
dermal edema are prominent, coinciding with the onset of
footpad swelling (Fig. 2A), and necrosis extends to compo-
nents of the subcutaneous tissue including fat. In advanced
lesions, the necrotic areas with abundant free bacilli and ab-
sence of cells reach considerable extension (Fig. 5F and G).
Eventually, multifocal microulcers emerge and result in exten-
sive ulceration of the epidermis; only at this advanced stage did
we observe secondary infection (data not shown).
Mice infected with 2 log10 AFB of M. ulcerans 98-912 (Fig.
2B) developed pathology with histological features similar to
those observed in mice infected with 5 log10 AFB of the same
strain, albeit with delayed kinetics (data not shown). We also
assessed whether M. ulcerans-infected mice could mount acute
inflammatory responses to reinfection with M. ulcerans. For
this purpose, the left footpads were infected with 5 log10 AFB
of M. ulcerans 98-912 until all mice showed progressive infec-
tion. After 35 days of infection, the contralateral footpads were
injected with a similar dose of M. ulcerans 98-912 and analyzed
after 10, 24, and 48 h. We found, in all experiments, that early,
acute inflammatory responses are initiated in a manner similar
to that described above for mice infected only once (data not
shown).
In contrast, mice infected with the avirulent strain 5114
showed absence of necrotic alterations during the whole ex-
perimental period (Fig. 4M to R). The initial neutrophilic
inflammatory process (Fig. 4M and N) was gradually replaced
FIG. 3. Kinetics of recruitment of macrophages and neutrophils to
the peritoneal cavity following infection with M. ulcerans. BALB/c
mice were infected intraperitoneally with 6.1 log10 AFB of M. ulcerans
98-912 (■) or 6.2 log10 AFB of M. ulcerans 5114 (F). Peritoneal cells
were recovered by peritoneal lavage, and the total number of leuko-
cytes was determined. Counting of neutrophils (solid lines) and mac-
rophages (dashed lines) was performed on Hemacolor-stained cyto-
spins. *, P  0.05; ***, P  0.001 (determined by Student’s t test,
comparing infected mice with mice inoculated with PBS). Results are
from one representative experiment of two independent experiments.
Error bars indicate standard deviations.
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FIG. 4. Histological sections of footpads of mice infected with M. ulcerans. BALB/c mice were infected with 5.9 log10 AFB of M. ulcerans 98-912
(A to F), 5.5 log10 AFB of M. ulcerans 97-1116 (G to L), or 5.8 log10 AFB of M. ulcerans 5114 (M to R). Footpads were collected at the indicated
times postinfection, and tissue sections were stained with HE (A, B, C, E, G, H, I, K, M, N, O, and Q) or ZN (D, F, J, L, P, and R). Magnifications,
60 (A, C, E, G, I, K, M, O, and Q) and 350 (B, D, F, H, J, L, N, P, and R). Panels A, B, G, H, M, and N show an acute inflammatory response
with predominance of neutrophils (arrows) early after infection by all strains of M. ulcerans. Panels C to F and I to L depict advanced stages of
infection with M. ulcerans 98-912 or 97-1116, respectively, and show necrosis of the central focus of infection (E, F, K, and L, asterisks) and high
numbers of extracellular bacteria (F and L), surrounded by a band of acute cellular infiltrate (E and K, arrowheads). In contrast, advanced stages
of infection with M. ulcerans 5114 show predominantly mononuclear infiltrates with intracellular bacilli, epithelioid transformation (O to R), and
granuloma-like organization (P). Results are from one representative experiment of two independent experiments.
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at the second week after infection by a predominantly lympho-
cytic and macrophagic infiltrate (Fig. 4O to R) with epithelioid
transformation, in the presence of a small number of neutro-
phils (Table 1). During the remaining time of experimental
infection, a predominance of lymphocytes, macrophages, and
giant cells was maintained, together with granuloma-like orga-
nization (Fig. 4P) and some neutrophils. We found intracellu-
lar bacilli throughout the whole experimental period of infec-
tion (Fig. 4P and R).
These observations confirmed the occurrence of an acute
cellular inflammation in the subcutaneous tissue, with the typ-
ical early and extensive recruitment of neutrophils in response
to the infection with different strains of M. ulcerans, irrespec-
tive of their virulence for mice. In addition, our data showed
that areas of cellular inflammation persist until the later stages
of infection, with a cellular pattern varying according to the
virulence of the strain.
Mouse-virulent strains of M. ulcerans induce postapoptotic
secondary necrosis. It has been shown that M. ulcerans and its
exotoxin mycolactone induce cell destruction in guinea pig skin
(22, 23), in fibroblast and macrophage cell lines (22, 23), and in
BMDM (Fig. 1E) by a cell death process with characteristics of
apoptosis. We found that the destructive process affecting cell
populations of acute inflammatory infiltrates in footpads in-
fected with mouse-virulent M. ulcerans strains, described in the
previous section, shows morphological features of apoptotic
cell death, namely pyknosis and karyorrhexis (77) (Fig. 6A, C,
and E) and TUNEL positivity of pyknotic and fragmented
nuclei (Fig. 6C). The dying cells were present in areas with
bacilli (Fig. 6D and F) or close to bacilli. However, we did not
find phagocytosis by macrophages of the cells undergoing apo-
ptosis. This observation, together with the presence of abun-
dant cell debris mixed with cells undergoing apoptosis (Fig. 6B
and E), indicates that the cell death process proceeds to sec-
ondary necrosis (77). Therefore, massive postapoptotic cell
lysis in the areas of acute inflammatory infiltrate rich in or
close to bacilli is the process responsible for the production of
expanding necrotic, acellular areas.
DISCUSSION
In humans, infections by M. ulcerans have been extensively
characterized by minimal or absent inflammation (1, 6, 8, 9, 12,
15, 21–26, 30, 31, 35, 45, 48, 52, 64), which contrasts with what
is known to occur with other mycobacterioses (3, 7, 10, 12, 36,
44, 51, 59, 60, 62, 72). On the other hand, the experimental
FIG. 5. Histological sections of lesions at late stages of infection with a mouse-virulent M. ulcerans strain. Footpads of mice infected with 5.9
log10 AFB of M. ulcerans 98-912 were analyzed at 16 (A, B, and C), 22 (D and E), or 28 (F and G) days postinfection. Tissue sections were stained
with ZN. Magnifications, 250 (A, D, and F) and 680 (B, C, E, and G). Panels A, D, and F show acellular necrotic areas that are extensive in
advanced infections (F), associated with extracellular bacilli (asterisks), surrounded by a band of acute inflammatory cellular infiltrate (A and D);
the acute infiltrate at the periphery of the necrotic area in F is outside the micrograph. Higher magnifications of the acute infiltrates in A and D
show intracellular bacilli (arrows in panels B, C, and E) and leukocyte death with pyknosis and karyorrhexis (arrowheads in panels C and E).
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models of infection by M. ulcerans led to contradictory results
regarding inflammatory responses (22, 23, 38, 40, 57, 75).
Therefore, comprehensive analyses of infection with different
M. ulcerans clinical isolates were carried out in mice to under-
stand the dynamics of inflammatory responses in an animal
model largely used in the study of experimental infections,
including mycobacteriosis (18, 47), and to compare the his-
topathological features of M. ulcerans infections in mice and
humans. Here we show that M. ulcerans induces relevant, vir-
ulence-dependent inflammatory responses in the mouse. The
mycolactone-negative, noncytotoxic strain does not produce
progressive infection and induces an initial acute neutrophilic
response that switches to a chronic mononuclear infiltrate as-
sociated with granuloma-like structures, in the absence of ne-
crosis. The two mycolactone-positive, cytotoxic strains multiply
progressively and induce an acute inflammatory response that
is permanently present during the infectious process, although
at spatially restricted areas surrounding a central necrotic,
acellular focus that expands with the progress of the disease.
The dynamics of the cellular response against infections has
been thoroughly described and is characterized by an early,
acute inflammation enriched in neutrophils, followed by re-
cruitment of monocytes that complement the activity of neu-
trophils (58). This biphasic phagocytic response is characteris-
tic of infections caused by pathogenic Mycobacterium species
related to M. ulcerans, such as M. tuberculosis and M. marinum
(3, 7, 36, 44, 51, 60, 62, 72), and was now found to occur also
in the mouse model of M. ulcerans infection. We show that the
M. ulcerans-induced initial inflammatory response is indistin-
guishable in mice infected with mycolactone-positive or -neg-
ative strains. This suggests that production of mycolactone by
M. ulcerans does not inhibit recruitment of phagocytes. The
comprehensive semiquantitative and blind histological analy-
ses carried out in the present study showed that in mice in-
fected with mouse-virulent M. ulcerans strains, acute leukocyte
responses are present, not only in the beginning of infection
but also throughout the entire murine infectious process until
ulceration of the footpad. Cell lysis in the acute inflammatory
infiltrate became evident early in the infection with these vir-
ulent strains and led to the production of expanding necrotic
areas. A band of acute cellular infiltrate is constantly present at
the periphery of these necrotic areas and is colonized with
FIG. 6. Histological sections of inflammatory infiltrates at early stages of infection with mouse-virulent M. ulcerans strains. Mouse footpads
were inoculated with 5.9 log10 AFB of M. ulcerans 98-912 (A to D) or 5.5 log10 AFB of M. ulcerans 97-1116 (E and F) for 24 h (A to D) or 48 h
(E and F). Serial tissue sections (A to D and E and F) were stained with HE (A, B, and E), TUNEL (C), or ZN (D and F). Magnifications, 750
(C), 1,000 (A, B, and E), and 1,250 (D and F). These panels show leukocyte cell death colocalized with bacilli in the acute inflammatory
infiltrate (D and F), with evidence of pyknosis (A and E, arrows), karyorrhexis (A, C, and E, arrowheads), and cellular debris (B and E, asterisks).
TUNEL staining (red nuclei and nuclear fragments in C) points to the apoptotic nature of cell death.
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intraphagocytic bacilli. In contrast, abundant extracellular ba-
cilli are seen in the expanding necrotic areas devoid of inflam-
matory cells. These necrotic areas reach considerable exten-
sion in advanced lesions and are similar to the necrotic areas
predominantly described in human biopsies. Whether the
above mechanism is behind the predominance of minimal or
absent inflammatory responses in BU biopsies remains to be
elucidated.
A switch from the initial acute, predominantly neutrophilic
response to a chronic, predominantly mononuclear response,
associated with epithelioid and giant cells and formation of
granulomas, is typical of mycobacterial infections when a cel-
lular-mediated immunity (CMI) is mounted (36, 44). As
shown, in progressive murine infection by virulent M. ulcerans,
such a switch is not fully completed. This observation corre-
lates with the finding that progressive infection of the skin,
disseminated disease, and osteomyelitis in BU patients were
associated with an absence of granulomas in the infected areas
(33, 49, 66). Conversely, with the noncytotoxic strain 5114,
which is not virulent for mice and does not cause leukocyte
death and necrosis of the subcutaneous tissue at any stage of
infection, the acute neutrophilic profile of the cellular infiltrate
gradually switches to a predominance of mononuclear cells and
formation of granuloma-like structures. Not surprisingly, this
type of chronic response was observed in BU patients during
the healing phase of disease (30, 31, 40, 49, 66, 74).
We were able to observe early and continued acute, pre-
dominantly neutrophilic responses to mouse-virulent M. ulcer-
ans strains because the small size of the diseased area allowed
the systematic observation of the entire lesion and surrounding
healthy tissues even in advanced infections when the areas of
necrosis are extensive.
Our interpretation is that the areas of minimal or absent
cellular inflammation seen in infected foci in mouse footpads
with advanced infections with virulent M. ulcerans strains are
due not to the lack of recruitment of inflammatory cells but
rather to the destruction of preexistent inflammatory infil-
trates. It is likely that such a destruction is due to the potent
cytotoxic activity of mycolactone, because lysing leukocytes
that colocalize with intracellular bacilli, or are in proximity to
extracellular bacilli, show morphological features compatible
to those described for the cytopathic activity of mycolactone
(22, 23) and do not occur with the mycolactone-negative strain.
Whether the observed difference in virulence for mice between
strains 98-912 and 97-1116 are related to possible differences in
the molecular structures of their mycolactones (34) requires
further investigations. The diffusibility of this exotoxin and the
high potency and wide cellular spectrum of its cytotoxicity
explain the difference between the peculiar histopathology of
M. ulcerans infections and that observed during infections with
other related mycobacterium species, such as M. marinum, M.
hemophilum, and M. tuberculosis.
Consequently, our observations show that the lack of signif-
icant inflammatory infiltrates in the necrotic areas of advanced
murine infections is not the result of an inhibition of recruit-
ment of inflammatory cells due to local immunosuppressive
activity of M. ulcerans (48, 52). The finding that recruitment of
inflammatory cells also occurs in the contralateral footpads of
mice with well-established progressive infections indicates that
systemic immunosuppression (24, 25) is not responsible for the
absence of inflammatory infiltrates, as well. Additionally, our
observations also argue against the suggestion that the minimal
or absent inflammation would be due to a lack of recruitment
of inflammatory cells, because the cell destruction occurring in
M. ulcerans-infected foci is due to apoptotic cell death (23).
Indeed, this death process is usually associated with absence of
inflammatory responses, because apoptotic cells are typically
phagocytosed before lysis (41). However, we observed that
apoptotic cells present in the infectious foci are not eliminated
by phagocytosis so that this cell death proceeds to lytic sec-
ondary necrosis (77). This appears to be due to the overwhelm-
ing extension of mycolactone-induced apoptosis that affects all
cell types of the infiltrate, including macrophages, the profes-
sional scavengers responsible for eliminating apoptotic cells
(41). It is well known that postapoptotic secondary necrosis is
a potent stimulus of inflammation, mainly when it affects high
numbers of neutrophils (28), leukocytes rich in highly cytotoxic
molecules (32).
In summary, we present here a time-lapse study of murine
infection with M. ulcerans that dissects the dynamic character-
istics of the host-parasite relationship at the site of active
infection. Our interpretation of the progression of infection
with virulent M. ulcerans in mouse footpads is as follows (Fig.
7). (i) Leukocyte death in the initial acute cellular infiltrate is
induced early after infection, resulting in necrotic, acellular
areas. Lysis of infected phagocytes results in the shedding of
bacilli that accumulate in the necrotic areas. (ii) The phlogistic
activity at the site of active infection and of cellular destruction
at the periphery of the necrotic areas recruits new inflamma-
tory infiltrates. (iii) In turn, the newly infected phagocytes are
lysed, and the cycle is repeated. The number of bacilli increases
and leads to the progressive invasion of adjacent healthy tissue
by bacilli and inflammatory infiltrates and expansion of the
necrotic area in a centrifugal manner. Consequently, from the
beginning of infection with virulent M. ulcerans in mice, acute
cellular inflammation is consistently present, although in ad-
vanced lesions it is spatially restricted to a narrow zone at the
periphery of extensive necrotic, acellular areas.
The occurrence of a persistent influx of neutrophils, mono-
cytes/macrophages and lymphocytes to the sites of active in-
fection, as shown in the present study, provides the continuous
availability of immune cells for interaction with M. ulcerans, as
is the case with other mycobacterioses. The occurrence of this
interaction in murine M. ulcerans infections is in accordance
with the observation that M. ulcerans-infected mice exhibit
CMI to both M. bovis BCG and its purified Ag85 complex (70).
As discussed above, in human M. ulcerans infections the oc-
currence of similar interactions has not been considered. In
fact, BU has been described as a disease with a histopatholog-
ical pattern characterized by minimal or absent inflammatory
responses and by the presence of abundant extracellular bacilli
in extensive necrotic, acellular areas (6, 8, 9, 27, 30, 31). Al-
though it is evident that such a histopathological pattern is a
diagnostic hallmark of BU, it may not reflect all the aspects of
the host-parasite interaction at the active infection foci. In-
deed, there are several lines of evidence implicating CMI and
delayed-type hypersensitivity responses in human M. ulcerans
infections, favoring the possible existence of a phase of intra-
cellularity of the pathogen, as follows. Studies with humans
show that resistance to M. ulcerans is associated with the Th1
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type of response (24, 25, 26, 55, 76), while a shift to a Th2
phenotype is related to susceptibility (26), and point to a pro-
tective effect of BCG vaccination (46, 53, 54, 63, 66, 73). Ad-
ditionally, as BU disease progresses to healing, granuloma
formation occurs (30, 31, 35, 40, 49, 66, 74), and the burulin
skin test (65) tends to change from negative to positive (13,
42). In contrast, disseminated disease and osteomyelitis were
reported to be associated with defects in granuloma formation
(33, 39).
Taking into account that (i) CMI and delayed-type hyper-
sensitivity occur not only in murine M. ulcerans infections but
also in human BU; (ii) in the murine model, as shown in this
study, extensive necrotic areas with extracellular bacilli that
resemble the classical BU histopathology coexist, in advanced
phases, with inflammatory infiltrates and intracellular bacilli;
(iii) there are reports describing inflammatory infiltrates with
intracellular bacilli in other animal models of infection; and
(iv) a recent publication (29) reports the occurrence of infil-
trates with neutrophils and mononuclear cells in 92% of 78
biopsies of confirmed BU, studies directed to the evaluation of
the interactions between phagocytes and M. ulcerans in human
infections are justified.
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